Innate immune response to gut-derived bacterial toxins in gastrointestinal andhepatic disorders

胃肠道和肝脏疾病中对肠源性细菌毒素的先天免疫反应

基本信息

  • 批准号:
    12470129
  • 负责人:
  • 金额:
    $ 7.36万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2002
  • 项目状态:
    已结题

项目摘要

Increasing lines of evidence have suggested a possible involvement of gut-derived bacterial toxins in various kinds of gastrointestinal and hepatic disorders including inflammatory bowel diseases (IBDs) and alcoholic liver disease (ALD). In the present study, we investigated the role of innate immune system that recognizes bacterial toxins [i.e., endotoxin (lipopolysaccharide, LPS) from Gram-negative bacteria] in ALD and IBDs.Regarding the pathogenesis of ALD, we investigated the expression pattern of Toll-like receptor (TLR)-4 and its downstream signaling molecules in the liver following acute ethanol treatment in mice. TLR-4 mRNA was detected constitutively in the normal liver tissue; however, it was decreased almost 90% within 6 hr after a single intragastric injection of ethanol (5 g/kg BW), followed by a gradual increase to the basal levels in 24 hr. In contrast, interleukin- 1 receptor associated kinase (IRAK) protein levels and its activity in Kupffer cells were increased 21 hr … More after acute ethanol injection. These findings most likely explain the mechanism of tolerance and sensitization of Kupffer cell to LPS in ethanol intoxication. Further, we evaluated the effect of thalidomide in an experimental model of alcoholic hepatitis in the rat. Thalidomide prevented activation of Kupffer cells due to gut-derived endotoxin , thereby protecting from alcohol-induced liver injury. This approach appears to be useful in patients of severe alcoholic hepatitis. In addition, we developed a new immuno-nutritional approach to IBDs using glycine, a non-essential amino acid. Glycine has been shown to prevent activation of macrophages and neutrophils due to bacterial toxins. In the present study, therefore, we evaluated whether dietary glycine prevents chemical-induced experimental colitis in the rats. Glycine prevented both TNBS- and DSS-induced colitis, which represent human Crohn's disease and ulcerative colitis, respectively, by decreasing induction of inflammatory cytokines and chemokines in the colonic tissue. It is postulated that glycine is useful for therapeutics of IBDs based on the mechanism that involves modulation of the innate immune system in the gut Less
越来越多的证据表明,肠道来源的细菌毒素可能参与各种胃肠道和肝脏疾病,包括炎症性肠病(IBD)和酒精性肝病(ALD)。在本研究中,我们研究了识别细菌毒素的先天免疫系统的作用[即,关于ALD的发病机制,我们研究了急性乙醇处理后小鼠肝脏中Toll样受体(TLR)-4及其下游信号分子的表达模式。TLR-4 mRNA在正常肝组织中呈组成型表达,但在单次灌胃乙醇(5g/kg BW)后6 h内下降近90%,24 h后逐渐升高至基础水平,而库普弗细胞中白细胞介素-1受体相关激酶(IRAK)蛋白水平及其活性在21 h后升高 ...更多信息 急性乙醇注射后。这些发现很可能解释了乙醇中毒时枯否细胞对LPS的耐受和增敏机制。此外,我们评估了沙利度胺在大鼠酒精性肝炎实验模型中的作用。沙利度胺可防止因肠源性内毒素引起的枯否细胞活化,从而防止酒精诱导的肝损伤。这种方法似乎对重度酒精性肝炎患者有用。此外,我们开发了一种新的免疫营养方法,使用甘氨酸,一种非必需氨基酸。甘氨酸已被证明可以防止由于细菌毒素引起的巨噬细胞和嗜中性粒细胞的活化。因此,在本研究中,我们评估了饮食中的甘氨酸是否可以预防大鼠化学诱导的实验性结肠炎。甘氨酸通过减少结肠组织中炎性细胞因子和趋化因子的诱导来预防TNBS诱导的结肠炎和DSS诱导的结肠炎,这分别代表人克罗恩病和溃疡性结肠炎。据推测,甘氨酸可用于IBD的治疗,其机制涉及调节肠道中的先天免疫系统。

项目成果

期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enomoto N, Takei Y, Hirose M, Ikejima K, Kitamura T, Sato N: "Thalidomide prevents alcoholic liver injury in rats through supression of Kupffer cell sensitization and TNF-α production."Gastroenterology. 123. 291-300 (2002)
Enomoto N、Takei Y、Hirose M、Ikejima K、Kitamura T、Sato N:“沙利度胺通过抑制 Kupffer 细胞致敏和 TNF-α 的产生来预防大鼠酒精性肝损伤。”胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shibuya T, Takei Y, Hirose M, Ikejima K, Enomoto N, Maruyama A, Sato N: "A double-stranded decoy DNA oligomer for NF-κB inhibits TNFα-induced ICAM1 expression in sinusoidal endothelial cells"Biochem.Biophys.Res.Commun.. 298. 10-16 (2002)
Shibuya T、Takei Y、Hirose M、Ikejima K、Enomoto N、Maruyama A、Sato N:“NF-κB 的双链诱饵 DNA 寡聚物抑制正弦内皮细胞中 TNFα 诱导的 ICAM1 表达”Biochem.Biophys.Res。通讯.. 298. 10-16 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei N, Sato N: "Leptin augments inflammatory and profibrogenic responses in the liver induced by acute carbon tetrachloride administration."Hepatology. 34(2). 288-297 (2001)
Ikejima K、Honda H、Yoshikawa M、Hirose M、Kitamura T、Takei N、Sato N:“瘦素增强急性四氯化碳给药诱导的肝脏炎症和促纤维化反应。”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikejima,K, Honda,H, Yoshikawa,M, Hirose,M, Kitamura,T, Takei,Y, Sato,N: "Leptin augments inflammatory and profibrogenic responses in the liver induced by acute carbon tetrachloride administration."Hepatology. 34(2). 288-297 (2001)
Ikejima,K, Honda,H, Yoshikawa,M, Hirose,M, Kitamura,T, Takei,Y, Sato,N:“瘦素增强急性四氯化碳给药诱导的肝脏炎症和促纤维化反应。”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Kitamura T, Sato N: "Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat"Gastroenterology. 122. 1399-1410 (2002
Ikejima K、Takei Y、Honda H、Hirose M、Yoshikawa M、Zhang YJ、Lang T、Fukuda T、Kitamura T、Sato N:“瘦素受体介导的信号调节大鼠肝纤维发生和细胞外基质重塑”胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SATO Nobuhiro其他文献

Structuring the Effects of Functional Recovery Care in a Private Home with Care Services for Older People
通过为老年人提供护理服务,构建私人住宅功能恢复护理的效果
  • DOI:
    10.14391/ajhs.19.1
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    FUJIO Yuko;NISHIBE Makoto;ARAKI Erika;SHIMADA Hiromi;SUGIYAMA Tomoko;SATO Nobuhiro
  • 通讯作者:
    SATO Nobuhiro

SATO Nobuhiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SATO Nobuhiro', 18)}}的其他基金

The "Shohin"as a Domain of No Genre:A Comprehensive Study of its Dynamics and Cultural History
作为无流派领域的“书品”:其动态与文化史的综合研究
  • 批准号:
    20520153
  • 财政年份:
    2008
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of pathophysiology and therapeutic strategies for metabolic syndrome-related steatohepatitis
代谢综合征相关脂肪性肝炎的病理生理学和治疗策略研究
  • 批准号:
    15390235
  • 财政年份:
    2003
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Multidisciplinary Study of the Origins and Development of 'Table Talk' in Modern Japan
现代日本“餐桌谈话”起源与发展的多学科研究
  • 批准号:
    15520122
  • 财政年份:
    2003
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the mechanisms for cytotoxic effects in the perforin/granzyme B system
穿孔素/颗粒酶B系统细胞毒作用机制分析
  • 批准号:
    14571221
  • 财政年份:
    2002
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The analysis of physical stimulation to proliferative gastric cells.
物理刺激对胃细胞增殖的分析。
  • 批准号:
    08457175
  • 财政年份:
    1996
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular and cell biological investigation about the healing mechanism of gastric mucosal damage.
胃粘膜损伤愈合机制的分子和细胞生物学研究。
  • 批准号:
    06454266
  • 财政年份:
    1994
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Developmental Research on Preservation of Liver Graft by Improving the Hepatic Microcirculation
改善肝脏微循环保肝的进展研究
  • 批准号:
    03454231
  • 财政年份:
    1991
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Development of an Endoscopic System for Treating cancerous lesions by Immunological - and medico - technological Modification of Tissue Microcirculation.
开发通过免疫学和医学技术改变组织微循环来治疗癌性病变的内窥镜系统。
  • 批准号:
    02557035
  • 财政年份:
    1990
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Disturbed Oxygen Metabolism Induced by Perturbation of Microcirculation.
微循环扰动引起的氧代谢紊乱。
  • 批准号:
    01480226
  • 财政年份:
    1989
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Dynamic Analysis of Hepatic Microcirculation and Hepatic Function by In vivo-Fluorescence Microscopy -Application to the Study of Pathogenesis and Treatment of Liver Diseases.
活体荧光显微镜动态分析肝脏微循环和肝功能-在肝病发病机制和治疗研究中的应用。
  • 批准号:
    62480195
  • 财政年份:
    1987
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Regulation of Linear Ubiquitin Signaling in Innate Immunity
先天免疫中线性泛素信号传导的调节
  • 批准号:
    MR/X036944/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Research Grant
Syudy on highly pathogenic avian influenza infection in innate immunity
Syudy 论高致病性禽流感感染的先天免疫
  • 批准号:
    23H02364
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidating the Intricate Interplay between Mitochondria, Innate Immunity, and Viral Pathogenesis in Heart Failure
阐明心力衰竭中线粒体、先天免疫和病毒发病机制之间复杂的相互作用
  • 批准号:
    491149
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Fellowship Programs
HIV Redirecting Innate Immunity by Vpu Targeting of JAK1
HIV 通过 Vpu 靶向 JAK1 重定向先天免疫
  • 批准号:
    10619889
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
Radioresistant Innate Immunity in SAVI Tissue-Specific Autoinflammation
SAVI 组织特异性自身炎症中的抗辐射先天免疫
  • 批准号:
    10752556
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
Developing a novel therapeutic strategy to overcome multidrug resistance in small-cell lung cancer by activating innate immunity
开发一种新的治疗策略,通过激活先天免疫来克服小细胞肺癌的多药耐药性
  • 批准号:
    23K07639
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
  • 批准号:
    10677304
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
Identification of plasma lipoprotein proteins and lipids as biomarkers of innate-immunity and vascular contributions to Alzheimer's disease and Alzheimer's disease-related dementias in older adults
鉴定血浆脂蛋白和脂质作为老年人阿尔茨海默病和阿尔茨海默病相关痴呆的先天免疫和血管贡献的生物标志物
  • 批准号:
    10660037
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
Regulation and Manipulation of Innate Immunity During HIV Infection
HIV 感染期间先天免疫的调节和操纵
  • 批准号:
    10874020
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
Role of ADAM9 in viral RNA sensing and antiviral innate immunity
ADAM9 在病毒 RNA 传感和抗病毒先天免疫中的作用
  • 批准号:
    10753041
  • 财政年份:
    2023
  • 资助金额:
    $ 7.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了